8-K
Current Report
Phio Pharmaceuticals Corp. Filed Acc 0001193125-17-006979
Material agreement · Acquisition or sale completed · Delisting notice · Executive or director change · Bylaws or fiscal year change
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d286088d8k.htm…